Polar Capital Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$259M Buy
281,102
+13,440
+5% +$13.6M 0.92% 29
2025
Q4
$288M Buy
267,662
+183,051
+216% +$175M 1.11% 24
2025
Q3
$64.6M Buy
84,611
+14,009
+20% +$10.4M 0.31% 80
2025
Q2
$55M Sell
70,602
-22,423
-24% -$17.4M 0.29% 85
2025
Q1
$76.8M Sell
93,025
-1,818
-2% -$1.51M 0.47% 63
2024
Q4
$73.2M Sell
94,843
-3,092
-3% -$2.56M 0.41% 62
2024
Q3
$86.8M Sell
97,935
-1,277
-1% -$1.15M 0.41% 53
2024
Q2
$89.8M Sell
99,212
-19,231
-16% -$15.4M 0.53% 52
2024
Q1
$92.1M Buy
118,443
+7,902
+7% +$5.62M 0.48% 49
2023
Q4
$64.4M Sell
110,541
-9,509
-8% -$5.55M 0.39% 72
2023
Q3
$64.5M Sell
120,050
-16,841
-12% -$8.68M 0.48% 60
2023
Q2
$64.2M Sell
136,891
-1,842
-1% -$772K 0.32% 75
2023
Q1
$47.6M Sell
138,733
-13,320
-9% -$4.49M 0.31% 87
2022
Q4
$55.6M Buy
152,053
+38,915
+34% +$13.8M 0.44% 73
2022
Q3
$36.6K Buy
113,138
+74,144
+190% +$23.5M 0.23% 94
2022
Q2
$12.6K Sell
38,994
-6,254
-14% -$1.88M 0.07% 181
2022
Q1
$13K Sell
45,248
-1,792
-4% -$461K 0.06% 211
2021
Q4
$13K Hold
47,040
0.05% 210
2021
Q3
$10.9K Buy
47,040
+8,588
+22% +$2.12M 0.04% 221
2021
Q2
$8.83K Buy
+38,452
New +$7.72M 0.04% 238
2021
Q1
Sell
-64,908
Closed -$11M 344
2020
Q4
$11M Buy
+64,908
New +$9.69M 0.07% 207

Other funds holding LLY

Polar Capital Holdings's LLY Position: Q1 2026 in Review

Polar Capital Holdings increased its Eli Lilly (LLY) stake by 5% in Q1 2026, buying an estimated $13.6M and bringing the position to 281,102 shares worth $259M. The position accounts for 0.92% of the portfolio, ranked #29.

Polar Capital Holdings first reported a position in LLY in Q4 2020 and has held it in 21 quarters since. The position peaked at $288M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Polar Capital Holdings held 281,102 shares of Eli Lilly worth $259M as of Q1 2026.
  • Polar Capital Holdings bought 13,440 Eli Lilly shares in Q1 2026, an estimated $13.6M.
  • Eli Lilly made up 0.92% of Polar Capital Holdings's portfolio in Q1 2026, its #29 holding.
  • Polar Capital Holdings first reported a position in Eli Lilly in Q4 2020 and has held it in 21 quarters since.
  • Polar Capital Holdings's Eli Lilly position peaked at $288M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Polar Capital Holdings's 13F filing for Q1 2026, filed 15 May 2026.